CC
MDT icon

Centiva Capital’s Medtronic MDT Stock Holding History

Centiva Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-60,200
Closed -$5.22M – 2083
2026
Q1 		$5.22M Buy
+60,200
New +$5.77M 0.04% 269
2024
Q4 		– Sell
-5,000
Closed -$450K – 2114
2024
Q3 		$450K Hold
5,000
– – 0.01% 1318
2024
Q2 		$394K Buy
+5,000
New +$410K 0.01% 1306
2022
Q4 		– Sell
-15,000
Closed -$1.21M – 1520
2022
Q3 		$1.21M Buy
+15,000
New +$1.35M 0.02% 531
2021
Q4 		– Sell
-20
Closed -$3K – 1409
2021
Q3 		$3K Buy
+20
New +$2.59K ﹤0.01% 1231

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Centiva Capital's MDT Position: Q2 2026 in Review

Centiva Capital sold out of Medtronic (MDT) in Q2 2026, closing a stake of 22,333 shares — an estimated $1.94M sold.

Centiva Capital first reported a position in MDT in Q4 2019 and held it in 18 quarters. The position peaked at $6.94M in Q3 2024. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Centiva Capital reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 22,333 Medtronic shares in Q2 2026, an estimated $1.94M.
  • Centiva Capital first reported a position in Medtronic in Q4 2019 and held it in 18 quarters.
  • Centiva Capital's Medtronic position peaked at $6.94M in Q3 2024.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.